Transarterial Embolization for Sporadic Renal Angiomyolipoma: Patient Selection and Technical Considerations for Optimal Therapeutic Outcomes.

Taehan Yongsang Uihakhoe chi Pub Date : 2022-05-01 Epub Date: 2021-12-23 DOI:10.3348/jksr.2021.0120
Yena Jung, Min Jeong Choi, Bong Man Kim, You Me Kim, Yumi Seo
{"title":"Transarterial Embolization for Sporadic Renal Angiomyolipoma: Patient Selection and Technical Considerations for Optimal Therapeutic Outcomes.","authors":"Yena Jung,&nbsp;Min Jeong Choi,&nbsp;Bong Man Kim,&nbsp;You Me Kim,&nbsp;Yumi Seo","doi":"10.3348/jksr.2021.0120","DOIUrl":null,"url":null,"abstract":"<p><p>Although renal angiomyolipoma (AML) is a benign tumor, treatment may be necessary occasionally because it can cause potentially life-threatening retroperitoneal hemorrhage. Transarterial embolization (TAE) is a safe and effective treatment option to prevent the hemorrhagic rupture of AMLs and relieve the symptoms caused by enlarged lesions or active bleeding. However, there is no clear consensus regarding the indications for prophylactic TAE in patients with sporadic renal AMLs. In urgent TAE for bleeding AMLs, there is a likelihood of incomplete embolization when the focus is on stabilizing the clinical symptoms. This pictorial essay discusses the patient selection and technical considerations to achieve optimal therapeutic effects as well as the follow-up findings after TAE.</p>","PeriodicalId":74904,"journal":{"name":"Taehan Yongsang Uihakhoe chi","volume":" ","pages":"559-581"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/5f/jksr-83-559.PMC9514513.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Taehan Yongsang Uihakhoe chi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3348/jksr.2021.0120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/12/23 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Although renal angiomyolipoma (AML) is a benign tumor, treatment may be necessary occasionally because it can cause potentially life-threatening retroperitoneal hemorrhage. Transarterial embolization (TAE) is a safe and effective treatment option to prevent the hemorrhagic rupture of AMLs and relieve the symptoms caused by enlarged lesions or active bleeding. However, there is no clear consensus regarding the indications for prophylactic TAE in patients with sporadic renal AMLs. In urgent TAE for bleeding AMLs, there is a likelihood of incomplete embolization when the focus is on stabilizing the clinical symptoms. This pictorial essay discusses the patient selection and technical considerations to achieve optimal therapeutic effects as well as the follow-up findings after TAE.

Abstract Image

Abstract Image

Abstract Image

经动脉栓塞治疗散发性肾血管平滑肌脂肪瘤:患者选择和最佳治疗结果的技术考虑。
虽然肾血管平滑肌脂肪瘤(AML)是一种良性肿瘤,但治疗有时是必要的,因为它可能导致潜在的危及生命的腹膜后出血。经动脉栓塞(TAE)是一种安全有效的治疗方法,可防止aml出血性破裂,缓解病变扩大或活动性出血引起的症状。然而,对于散发性肾aml患者预防性TAE的适应症尚无明确的共识。在出血aml的紧急TAE中,当重点是稳定临床症状时,可能存在不完全栓塞的可能性。这篇图片文章讨论了患者的选择和技术考虑,以达到最佳的治疗效果,以及TAE后的随访结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信